{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T09:18:24Z","timestamp":1792919904233,"version":"4.5.0"},"reference-count":145,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["2000111201"],"award-info":[{"award-number":["2000111201"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.critrevonc.2017.03.020","type":"journal-article","created":{"date-parts":[[2017,3,18]],"date-time":"2017-03-18T18:30:17Z","timestamp":1489861817000},"page":"304-317","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":93,"special_numbering":"C","title":["Lymphoblastic lymphoma"],"prefix":"10.1016","volume":"113","author":[{"given":"Sergio","family":"Cortelazzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"Ferreri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Hoelzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurilio","family":"Ponzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.critrevonc.2017.03.020_bib0005","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.bbmt.2005.07.001","article-title":"Chemotherapy and hematopoietic stem cell transplantation for adult T-cell lymphoblastic lymphoma: current status and controversies","volume":"11","author":"Aljurf","year":"2005","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"17","key":"10.1016\/j.critrevonc.2017.03.020_bib0010","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.3748\/wjg.v13.i17.2436","article-title":"Epidemiology of hepatitis C virus infection","volume":"13","author":"Alter","year":"2007","journal-title":"World J. Gastroenterol."},{"issue":"10","key":"10.1016\/j.critrevonc.2017.03.020_bib0015","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1056\/NEJM198303103081003","article-title":"Childhood non-Hodgkin\u2019s lymphoma: the results of a randomized therapeutic trial comparing a 4-drug regimen (COMP) with a 10-drug regimen (LSA2-L2)","volume":"308","author":"Anderson","year":"1983","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.critrevonc.2017.03.020_bib0020","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1200\/JCO.1993.11.6.1024","article-title":"Long-term follow-up of patients treated with COMP or LSA2L2 therapy for childhood non-Hodgkin\u2019s lymphoma: a report of CCG-551 from the Childrens Cancer Group","volume":"11","author":"Anderson","year":"1993","journal-title":"J. Clin. Oncol."},{"issue":"Suppl. 3","key":"10.1016\/j.critrevonc.2017.03.020_bib0025","first-page":"573","article-title":"Critical windows of exposure for children\u2019s health: cancer in human epidemiological studies and neoplasms in experimental animal models","volume":"108","author":"Anderson","year":"2000","journal-title":"Environ. Health Perspect."},{"issue":"6","key":"10.1016\/j.critrevonc.2017.03.020_bib0030","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/pbc.22209","article-title":"A phase II study of Campath-1H in children with relapsed or refractory acute lymphoblastic leukemia: a Children\u2019s Oncology Group report","volume":"53","author":"Angiolillo","year":"2009","journal-title":"Pediatr. Blood Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2017.03.020_bib0035","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/pbc.20121","article-title":"Outcome of children with primary resistant or relapsed non-Hodgkin lymphoma and mature B-cell leukemia after intensive first line treatment: a population-based analysis of the Austrian Cooperative Study Group","volume":"44","author":"Attarbaschi","year":"2005","journal-title":"Pediatr. Blood Cancer"},{"issue":"9","key":"10.1016\/j.critrevonc.2017.03.020_bib0040","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1002\/ijc.28854","article-title":"Parental occupational pesticide exposure and the risk of childhood leukemia in the offspring: findings from the Childhood Leukemia International Consortium","volume":"135","author":"Bailey","year":"2014","journal-title":"Int. J. Cancer"},{"issue":"11","key":"10.1016\/j.critrevonc.2017.03.020_bib0045","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1002\/ijc.29631","article-title":"Home pesticide exposures and risk of childhood leukemia: findings from the childhood leukemia international consortium","volume":"137","author":"Bailey","year":"2015","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2017.03.020_bib0050","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1158\/1078-0432.CCR-07-1927","article-title":"T cell receptor genotyping and HOXA\/TLX1 expression define three T lymphoblastic lymphoma subsets which might affect clinical outcome","volume":"14","author":"Baleydier","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.critrevonc.2017.03.020_bib0055","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/ajh.23167","article-title":"Clofarabine-based chemotherapy for relapsed\/refractory adult acute lymphoblastic leukemia and lymphoblastic lymphoma. Spanish experience","volume":"87","author":"Barba","year":"2012","journal-title":"Am. J. Hematol."},{"issue":"1","key":"10.1016\/j.critrevonc.2017.03.020_bib0060","first-page":"33","article-title":"Autologous bone marrow transplantation in 22 adult patients with lymphoblastic lymphoma responsive to conventional dose chemotherapy","volume":"10","author":"Baro","year":"1992","journal-title":"Bone Marrow Transplant."},{"issue":"18","key":"10.1016\/j.critrevonc.2017.03.020_bib0065","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1182\/blood-2008-11-185132","article-title":"Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL)","volume":"113","author":"Bassan","year":"2009","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.critrevonc.2017.03.020_bib0070","doi-asserted-by":"crossref","first-page":"786","DOI":"10.3324\/haematol.2014.123273","article-title":"Randomized trial of radiation-free central nervous system prophylaxis comparing intrathecal triple therapy with liposomal cytarabine in acute lymphoblastic leukemia","volume":"100","author":"Bassan","year":"2015","journal-title":"Haematologica"},{"issue":"12","key":"10.1016\/j.critrevonc.2017.03.020_bib0075","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/gcc.20924","article-title":"T-cell lymphoblastic lymphoma shows differences and similarities with T-cell acute lymphoblastic leukemia by genomic and gene expression analyses","volume":"50","author":"Basso","year":"2011","journal-title":"Genes Chromosome Cancer"},{"issue":"6","key":"10.1016\/j.critrevonc.2017.03.020_bib0080","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1182\/blood.V57.6.1105.1105","article-title":"Cell surface characterization of malignant T cells from lymphoblastic lymphoma using monoclonal antibodies: evidence for phenotypic differences between malignant T cells from patients with acute lymphoblastic leukemia and lymphoblastic lymphoma","volume":"57","author":"Bernard","year":"1981","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.critrevonc.2017.03.020_bib0085","doi-asserted-by":"crossref","first-page":"680","DOI":"10.3109\/0284186X.2013.855816","article-title":"Multimodal treatment with ALL-like chemotherapy: auto-SCT and radiotherapy for lymphoblastic lymphoma","volume":"53","author":"Bersvendsen","year":"2014","journal-title":"Acta Oncol."},{"issue":"12","key":"10.1016\/j.critrevonc.2017.03.020_bib0090","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1056\/NEJM199603213341201","article-title":"Breast cancer and other second neoplasms after childhood Hodgkin\u2019s disease","volume":"334","author":"Bhatia","year":"1996","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.critrevonc.2017.03.020_bib0095","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/pbc.20334","article-title":"Reduction of adult height in childhood acute lymphoblastic leukemia survivors after prophylactic cranial irradiation","volume":"45","author":"Bongers","year":"2005","journal-title":"Pediatr. Blood Cancer"},{"issue":"16","key":"10.1016\/j.critrevonc.2017.03.020_bib0100","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1182\/blood-2012-12-474148","article-title":"Incidence and prognostic relevance of genetic variations in T-cell lymphoblastic lymphoma in childhood and adolescence","volume":"121","author":"Bonn","year":"2013","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.critrevonc.2017.03.020_bib0105","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/bjh.13105","article-title":"Whole exome sequencing hints at a unique mutational profile of paediatric T-cell lymphoblastic lymphoma","volume":"168","author":"Bonn","year":"2015","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2017.03.020_bib0110","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"176","article-title":"T lymphoblastic leukaemia\/lymphoma","author":"Borowitz","year":"2008"},{"key":"10.1016\/j.critrevonc.2017.03.020_bib0115","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"168","article-title":"B lymphoblastic leukaemia\/lymphoma, not otherwise specified","author":"Borowitz","year":"2008"},{"key":"10.1016\/j.critrevonc.2017.03.020_bib0120","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"171","year":"2008"},{"issue":"6","key":"10.1016\/j.critrevonc.2017.03.020_bib0125","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1023\/A:1008202808144","article-title":"Role of induction chemotherapy and bone marrow transplantation in adult lymphoblastic lymphoma: a report on 62 patients from a single center","volume":"9","author":"Bouabdallah","year":"1998","journal-title":"Ann. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2017.03.020_bib0130","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1200\/JCO.2005.02.2707","article-title":"Impact of cranial radiotherapy on central nervous system prophylaxis in children and adolescents with central nervous system-negative stage III or IV lymphoblastic lymphoma","volume":"24","author":"Burkhardt","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"20","key":"10.1016\/j.critrevonc.2017.03.020_bib0135","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1200\/JCO.2008.19.3367","article-title":"Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the Berlin-Frankfurt-Muenster Group","volume":"27","author":"Burkhardt","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"16","key":"10.1016\/j.critrevonc.2017.03.020_bib0140","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1200\/JCO.2011.39.7661","article-title":"Clinical impact of NOTCH1 and\/or FBXW7 mutations: FLASH deletion, and TCR status in pediatric T-cell lymphoblastic lymphoma","volume":"30","author":"Callens","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.critrevonc.2017.03.020_bib0145","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.3109\/10428194.2013.871279","article-title":"Dexamethasone: methotrexate, ifosfamide, L-asparaginase and etoposide (SMILE) chemotherapy for relapsed or refractory adult lymphoblastic lymphoma","volume":"55","author":"Chang","year":"2014","journal-title":"Leuk. Lymphoma"},{"issue":"2","key":"10.1016\/j.critrevonc.2017.03.020_bib0150","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.critrevonc.2013.12.004","article-title":"Occupational exposures in rare cancers: a critical review of the literature","volume":"90","author":"Charbotel","year":"2014","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"4","key":"10.1016\/j.critrevonc.2017.03.020_bib0155","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","article-title":"Report of an international workshop to standardize response criteria for non- Hodgkin\u2019s lymphomas. NCI Sponsored International Working Group","volume":"17","author":"Cheson","year":"1999","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.critrevonc.2017.03.020_bib0160","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1200\/JCO.1986.4.11.1628","article-title":"Treatment of lymphoblastic lymphoma in adults","volume":"4","author":"Coleman","year":"1986","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2017.03.020_bib0165","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1365-2141.2010.08236.x","article-title":"Cyclophosphamide in relapsed\/refractory paediatric T-cell lymphoblastic leukaemia and lymphoma","volume":"150","author":"Commander","year":"2010","journal-title":"Br. J. Haematol."},{"issue":"Suppl. 1","key":"10.1016\/j.critrevonc.2017.03.020_bib0170","first-page":"477a","article-title":"Autologous stem cell transplantation (ASCT) for LBL (LBL)","volume":"94","author":"Conde","year":"1999","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.critrevonc.2017.03.020_bib0175","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1182\/blood.V85.5.1151.bloodjournal8551151","article-title":"The biology and treatment of acute lymphoblastic leukemia in adults","volume":"85","author":"Copelan","year":"1995","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.critrevonc.2017.03.020_bib0180","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00277-011-1252-x","article-title":"Results of a lymphoblastic leukemia-like chemotherapy program with risk adapted mediastinal irradiation and stem cell transplantation for adult patients with lymphoblastic lymphoma","volume":"91","author":"Cortelazzo","year":"2012","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.critrevonc.2017.03.020_bib0185","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1182\/blood.V110.11.3564.3564","article-title":"A novel approach for minimal residual disease detection in childhood T-cell lymphoblastic lymphoma (T-LL): a children\u2019s oncology group report","volume":"110","author":"Coustan-Smith","year":"2007","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.critrevonc.2017.03.020_bib0190","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1038\/modpathol.3800694","article-title":"Differential expression of the novel oncogene: SALL4, in lymphoma, plasma cell myeloma, and acute lymphoblastic leukemia","volume":"19","author":"Cui","year":"2006","journal-title":"Mod. Pathol."},{"issue":"5","key":"10.1016\/j.critrevonc.2017.03.020_bib0195","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1182\/blood.V66.5.1110.1110","article-title":"A novel treatment of childhood lymphoblastic non-Hodgkin\u2019s lymphoma: early and intermittent use of teniposide plus cytarabine","volume":"66","author":"Dahl","year":"1985","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.critrevonc.2017.03.020_bib0200","doi-asserted-by":"crossref","first-page":"5136","DOI":"10.1182\/blood-2006-11-056754","article-title":"Nelarabine induces complete remissions in adults with relapsed or refractory T lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: cancer and Leukemia Group B study 19801","volume":"109","author":"De Angelo","year":"2007","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.critrevonc.2017.03.020_bib0205","first-page":"767","article-title":"Role of allogenic bone marrow transplantation in adolescent or adult patients with acute lymphoblastic leukaemia or lymphoblastic lymphoma in first remission","volume":"14","author":"De Witte","year":"1994","journal-title":"Bone Marrow Transplant."},{"issue":"4","key":"10.1016\/j.critrevonc.2017.03.020_bib0210","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1365-2141.2010.08541.x","article-title":"Clinical presentation: evolution, and prognosis of precursor B-cell lymphoblastic lymphoma in trials LMT96, EORTC 58881, and EORTC58951","volume":"152","author":"Ducassou","year":"2011","journal-title":"Br. J. Haematol."},{"issue":"8","key":"10.1016\/j.critrevonc.2017.03.020_bib0215","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1182\/blood-2007-10-119974","article-title":"Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium","volume":"111","author":"Ekstrom Smedby","year":"2008","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.critrevonc.2017.03.020_bib0220","doi-asserted-by":"crossref","first-page":"927","DOI":"10.3109\/0284186X.2014.889850","article-title":"Treatment outcome in T-cell lymphoblastic lymphoma in adults \u2212a population-based study from the Swedish Lymphoma Registry","volume":"53","author":"Ellin","year":"2014","journal-title":"Acta Oncol."},{"key":"10.1016\/j.critrevonc.2017.03.020_bib0225","first-page":"1391","article-title":"LBL: results of a prospective treatment trial (BMFT study)","volume":"93","author":"Engelhard","year":"1996","journal-title":"Br. J. Heatol."},{"issue":"12","key":"10.1016\/j.critrevonc.2017.03.020_bib0230","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/aje\/kwi341","article-title":"Immune-related conditions and immune-modulating medications as risk factors for non-Hodgkin\u2019s lymphoma: a case-control study","volume":"162","author":"Engels","year":"2005","journal-title":"Am. J. Epidemiol."},{"issue":"3","key":"10.1016\/j.critrevonc.2017.03.020_bib0235","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.clml.2013.12.001","article-title":"Phase I and extension study of clofarabine plus cyclophosphamide in patients with relapsed\/refractory acute lymphoblastic leukemia","volume":"14","author":"Faderl","year":"2014","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"10.1016\/j.critrevonc.2017.03.020_bib0240","series-title":"Acute Leukemias","first-page":"167","article-title":"Treatment of adult ALL according to the protocols of the German Multicenter Study Group for Adult ALL","author":"G\u00f6kbuget","year":"2008"},{"issue":"13","key":"10.1016\/j.critrevonc.2017.03.020_bib0245","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1182\/blood-2011-01-329441","article-title":"High single-drug activity of nelarabine in relapsed T-lymphoblastic leukemia\/lymphoma offers curative option with subsequent stem cell transplantation","volume":"118","author":"G\u00f6kbuget","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2017.03.020_bib0250","first-page":"124","article-title":"Favorable outcome in a large cohort of prospectively treated adult patients with T-lymphoblastic lymphoma (T-LBL) despite slowly evolving complete remission assessed by conventional radiography","author":"G\u00f6kbuget","year":"2014","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.critrevonc.2017.03.020_bib0255","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1470-2045(13)70548-5","article-title":"Childhood cancer survival in Europe 1999\u20132007: results of EUROCARE-5\u2013a population-based study","volume":"15","author":"Gatta","year":"2014","journal-title":"Lancet Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2017.03.020_bib0260","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1016\/j.clml.2014.01.004","article-title":"Extramedullary B lymphoblastic leukemia\/lymphoma (B-ALL\/BLBL): a diagnostic challenge","volume":"14","author":"Geethakumari","year":"2014","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"23","key":"10.1016\/j.critrevonc.2017.03.020_bib0265","doi-asserted-by":"crossref","first-page":"4395","DOI":"10.1200\/JCO.2003.04.089","article-title":"Impact of CNS treatment on mood in adult survivors of childhood leukemia: a report from the Children\u2019s Cancer Group","volume":"21","author":"Glover","year":"2003","journal-title":"J. Clin. Oncol."},{"issue":"15","key":"10.1016\/j.critrevonc.2017.03.020_bib0270","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1093\/jnci\/92.15.1240","article-title":"Cancer surveillance series: non-Hodgkin\u2019s lymphoma incidence by histologic subtype in the United States from 1978 through 1995","volume":"92","author":"Groves","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"issue":"7","key":"10.1016\/j.critrevonc.2017.03.020_bib0275","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1200\/JCO.1993.11.7.1208","article-title":"Cardiac disease following treatment of Hodgkin\u2019s disease in children and adolescents","volume":"11","author":"Hancock","year":"1993","journal-title":"J. Clin. Oncol."},{"issue":"9199","key":"10.1016\/j.critrevonc.2017.03.020_bib0280","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0140-6736(99)05264-2","article-title":"Risks of leukaemia and solid tumours in individuals with Down\u2019s syndrome","volume":"355","author":"Hasle","year":"2000","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.critrevonc.2017.03.020_bib0285","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1053\/beha.2002.0230","article-title":"Treatment of lymphoblastic lymphoma in adults","volume":"15","author":"Hoelzer","year":"2002","journal-title":"Best Pract. Res. Clin. Haematol."},{"issue":"12","key":"10.1016\/j.critrevonc.2017.03.020_bib0290","doi-asserted-by":"crossref","first-page":"4379","DOI":"10.1182\/blood-2002-01-0110","article-title":"Outcome of adult patients with T-lymphoblastic lymphoma treated according to protocols for acute lymphoblastic leukemia","volume":"99","author":"Hoelzer","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2017.03.020_bib0295","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2013.31.15_suppl.10003","article-title":"Bortezomib reinduction therapy to improve response rates in pediatric ALL in first relapse: a Children\u2019s Oncology Group (COG) study (AALL07P1)","volume":"31","author":"Horton","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2017.03.020_bib0300","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1200\/JCO.1988.6.1.26","article-title":"Lymphoblastic lymphoma in children \u2212a randomized trial comparing LSA2-L2 with the A-COP+therapeutic regimen: a Pediatric Oncology Group Study","volume":"6","author":"Hvizdala","year":"1988","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2017.03.020_bib0305","first-page":"987","article-title":"A predictive model for aggressive non-Hodgkin\u2019s lymphoma. The international non-Hodgkin\u2019s lymphoma prognostic factors project","volume":"32914","author":"INHLPFP","year":"1993","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.critrevonc.2017.03.020_bib0310","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/bjc.1987.91","article-title":"Second malignancies in children treated for non-Hodgkin\u2019s lymphoma and T-cell leukaemia with the UKCCSG regimens","volume":"55","author":"Ingram","year":"1987","journal-title":"Br. J. Cancer"},{"issue":"7","key":"10.1016\/j.critrevonc.2017.03.020_bib0315","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1182\/blood.V85.7.1881.bloodjournal8571881","article-title":"A syndrome of lymphoblastic lymphoma, eosinophilia, and myeloid hyperplasia\/malignancy associated with t(8; 13)(p11; q11): description of a distinctive clinicopathologic entity","volume":"85","author":"Inhorn","year":"1995","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.critrevonc.2017.03.020_bib0320","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/sj.leu.2404156","article-title":"High survival rate with the LMT-89 regimen in lymphoblastic lymphoma (LL): but not in T-cell acute lymphoblastic leukemia (T-ALL)","volume":"20","author":"Jabbour","year":"2006","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.critrevonc.2017.03.020_bib0325","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/leu.2013.312","article-title":"The combination of hyper-CVAD plus nelarabine as frontline therapy in adult Tcell acute lymphoblastic leukemia and T-lymphoblastic lymphoma: MD Anderson Cancer Center experience","volume":"28","author":"Jain","year":"2014","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.critrevonc.2017.03.020_bib0330","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s00277-014-2258-y","article-title":"Multicenter analysis of treatment outcomes in adult patients with lymphoblastic lymphoma who received hyper-CVAD induction followed by hematopoietic stem cell transplantation","volume":"94","author":"Jeong","year":"2015","journal-title":"Ann. Hematol."},{"issue":"5","key":"10.1016\/j.critrevonc.2017.03.020_bib0335","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/oxfordjournals.annonc.a059214","article-title":"Short-term weekly chemotherapy followed by high-dose therapy with autologous bone marrow transplantation for lymphoblastic and Burkitt\u2019s lymphomas in adult patients","volume":"6","author":"Jost","year":"1995","journal-title":"Ann. Oncol."},{"issue":"10","key":"10.1016\/j.critrevonc.2017.03.020_bib0340","first-page":"672","article-title":"Clinical characteristics of infant acute leukemia with or without 11q23 translocations","volume":"2","author":"Kaneko","year":"1988","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.critrevonc.2017.03.020_bib0345","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.cancergen.2014.05.011","article-title":"Molecular identification of a TPR-FGFR1 fusion transcript in an adult with myeloproliferative neoplasm, T-lymphoblastic lymphoma, and a t(1; 8)(q25; p11.2)","volume":"207","author":"Kim","year":"2014","journal-title":"Cancer Genet."},{"issue":"2","key":"10.1016\/j.critrevonc.2017.03.020_bib0350","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00000478-199702000-00016","article-title":"Lymphoblastic lymphoma expressing natural killer cell phenotype with involvement of the mediastinum and nasal cavity","volume":"21","author":"Koita","year":"1997","journal-title":"Am. J. Surg. Pathol."},{"issue":"5","key":"10.1016\/j.critrevonc.2017.03.020_bib0355","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/mpo.10055","article-title":"CNS late-effects after ALL therapy in childhood, Part III: neuropsychological performance in long-term survivors of childhood ALL: impairments of concentration, attention, and memory","volume":"38","author":"Langer","year":"2002","journal-title":"Med. Pediatr. Oncol."},{"issue":"8","key":"10.1016\/j.critrevonc.2017.03.020_bib0360","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/ajh.22071","article-title":"Myeloablative allogeneic stem cell transplantation for lymphoblastic lymphoma in Sweden: a retrospective study","volume":"86","author":"Lazarevic","year":"2011","journal-title":"Am. J. Hematol."},{"issue":"11","key":"10.1016\/j.critrevonc.2017.03.020_bib0365","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1038\/sj.leu.2403095","article-title":"Adult lymphoblastic lymphoma: a retrospective analysis of 92 patients under 61 years included in the LNH87\/93 trials","volume":"17","author":"Le","year":"2003","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.critrevonc.2017.03.020_bib0370","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1200\/JCO.2015.61.5385","article-title":"Pediatric-like acute lymphoblastic leukemia therapy in adults with lymphoblastic lymphoma. The GRAAL-LYSA LL03 study","volume":"34","author":"Lepretre","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.critrevonc.2017.03.020_bib0375","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1182\/blood-2002-05-1483","article-title":"A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma","volume":"101","author":"Levine","year":"2003","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.critrevonc.2017.03.020_bib0380","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.taap.2003.12.032","article-title":"Causes of childhood leukaemia and lymphoma","volume":"199","author":"Lightfoot","year":"2004","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"17","key":"10.1016\/j.critrevonc.2017.03.020_bib0385","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1056\/NEJM199004263221701","article-title":"Results of treatment of childhood localized non-Hodgkin\u2019s lymphoma with combination chemotherapy with or without radiotherapy","volume":"322","author":"Link","year":"1990","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.critrevonc.2017.03.020_bib0390","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1365-2141.2009.07882.x","article-title":"Clofarabine: cyclophosphamide and etoposide as single-course re-induction therapy for children with refractory\/multiple relapsed acute lymphoblastic leukaemia","volume":"147","author":"Locatelli","year":"2009","journal-title":"Br. J. Haematol."},{"issue":"9","key":"10.1016\/j.critrevonc.2017.03.020_bib0395","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1200\/JCO.2002.06.017","article-title":"Non-Hodgkin\u2019s lymphoma arising in bone in children and adolescents is associated with an excellent outcome: a Children\u2019s Cancer Group report","volume":"20","author":"Lones","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2017.03.020_bib0400","article-title":"Nelarabine, cyclosphosphamide and etoposide for adults with relapsed Tcell acute lymphoblastic leukaemia and lymphoma","author":"Luskin","year":"2015","journal-title":"Br. J. Haematol."},{"issue":"5","key":"10.1016\/j.critrevonc.2017.03.020_bib0405","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.0902-4441.2006.t01-1-EJH2889.x","article-title":"Treatment with bortezomib in a patient with heavily pretreated refractory T-cell lymphoblastic lymphoma","volume":"77","author":"Mai","year":"2006","journal-title":"Eur. J. Haematol."},{"issue":"1","key":"10.1016\/j.critrevonc.2017.03.020_bib0410","doi-asserted-by":"crossref","first-page":"e2015001","DOI":"10.4084\/mjhid.2015.001","article-title":"Modern immunotherapy of adult B-lineage acute lymphoblastic leukemia with monoclonal antibodies and chimeric antigen receptor modified T cells","volume":"7","author":"Maino","year":"2015","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"issue":"6","key":"10.1016\/j.critrevonc.2017.03.020_bib0415","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1309\/Q5GV-3K00-WAC6-BBUB","article-title":"Precursor B-cell lymphoblastic lymphoma: a study of nine cases lacking blood and bone marrow involvement and review of the literature","volume":"115","author":"Maitra","year":"2001","journal-title":"Am. J. Clin. Pathol."},{"issue":"9168","key":"10.1016\/j.critrevonc.2017.03.020_bib0420","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/S0140-6736(98)09460-4","article-title":"Human T-lymphotropic virus type I infection","volume":"353","author":"Manns","year":"1999","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.critrevonc.2017.03.020_bib0425","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1542\/peds.100.1.60","article-title":"Cutaneous involvement in children with acute lymphoblastic leukemia or lymphoblastic lymphoma. The Children\u2019s Leukemia Cooperative Group of the European Organization of Research and Treatment of Cancer (EORTC)","volume":"100","author":"Millot","year":"1997","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.critrevonc.2017.03.020_bib0430","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1002\/cncr.11615","article-title":"Lymphoblastic lymphoma of childhood and the LSA2-L2 protocol: the 30-year experience at Memorial-Sloan-Kettering Cancer Center","volume":"98","author":"Mora","year":"2003","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.critrevonc.2017.03.020_bib0435","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1200\/JCO.1992.10.7.1078","article-title":"Prognosis and treatment of lymphoblastic lymphoma in adults: a report on 80 patients","volume":"10","author":"Morel","year":"1992","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2017.03.020_bib0440","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/ijc.2910430214","article-title":"Modelling the risk of adult T-cell leukemia\/lymphoma in persons infected with human T-lymphotropic virus type I","volume":"43","author":"Murphy","year":"1989","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2017.03.020_bib0445","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1200\/JCO.1989.7.2.186","article-title":"Non-Hodgkin\u2019s lymphomas of childhood: an analysis of the histology, staging, and response to treatment of 338 cases at a single institution","volume":"7","author":"Murphy","year":"1989","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.critrevonc.2017.03.020_bib0450","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.1182\/blood.V89.12.4665","article-title":"Acute lymphoblastic leukemia\/lymphoblastic lymphoma of natural killer (NK) lineage: quest for another NK-lineage neoplasm","volume":"89","author":"Nakamura","year":"1997","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.critrevonc.2017.03.020_bib0455","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1182\/blood-2006-08-039024","article-title":"The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas","volume":"109","author":"Natkunam","year":"2007","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.critrevonc.2017.03.020_bib0460","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/1096-911X(200007)35:1<20::AID-MPO4>3.0.CO;2-L","article-title":"Precursor B-cell lymphoblastic lymphoma in childhood and adolescence: clinical features, treatment, and results in trials NHL-BFM 86 and 90","volume":"35","author":"Neth","year":"2000","journal-title":"Med. Pediatr. Oncol."},{"issue":"9","key":"10.1016\/j.critrevonc.2017.03.020_bib0465","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.3324\/haematol.2014.105452","article-title":"PDGFRB-rearranged T-lymphoblastic leukemia\/lymphoma occurring with myeloid neoplasms: the missing link supporting a stem cell origin","volume":"99","author":"Ondrejka","year":"2014","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.critrevonc.2017.03.020_bib0470","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1097\/PAS.0b013e318213e90e","article-title":"Diagnosis and immunophenotype of 188 pediatric lymphoblastic lymphomas treated within a randomized prospective trial: experiences and preliminary recommendations from the European childhood lymphoma pathology panel","volume":"35","author":"Oschlies","year":"2011","journal-title":"Am. J. Surg. Pathol."},{"issue":"9","key":"10.1016\/j.critrevonc.2017.03.020_bib0475","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/ng.430","article-title":"Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia","volume":"41","author":"Papaemmanuil","year":"2009","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.critrevonc.2017.03.020_bib0480","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/bjh.12042","article-title":"The immunophenotype of T-lymphoblastic lymphoma in children and adolescents: a Children\u2019s Oncology Group report","volume":"159","author":"Patel","year":"2012","journal-title":"Br. J. Haematol."},{"issue":"2","key":"10.1016\/j.critrevonc.2017.03.020_bib0485","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/mpo.2950200204","article-title":"Results of the LMT81 protocol: a modified LSA2L2 protocol with high dose methotrexate, on 84 children with non-B-cell (lymphoblastic) lymphoma","volume":"20","author":"Patte","year":"1992","journal-title":"Med. Pediatr. Oncol."},{"issue":"8","key":"10.1016\/j.critrevonc.2017.03.020_bib0490","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1182\/blood.V81.8.2003.2003","article-title":"Curability of relapsed childhood B-cell non-Hodgkin\u2019s lymphoma after intensive first line therapy: a report from the Societe Francaise d\u2019Oncologie Pediatrique","volume":"81","author":"Philip","year":"1993","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.critrevonc.2017.03.020_bib0495","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/pbc.22162","article-title":"Long-term results of AIEOP LNH-92 protocol for the treatment of pediatric lymphoblastic lymphoma: a report of the Italian Association of Pediatric Hematology and Oncology","volume":"53","author":"Pillon","year":"2009","journal-title":"Pediatr. Blood Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2017.03.020_bib0500","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/(SICI)1096-9896(1998100)186:2<140::AID-PATH149>3.0.CO;2-Y","article-title":"Co-expression of CD79a (JCB117) and CD3 by lymphoblastic lymphoma","volume":"186","author":"Pilozzi","year":"1998","journal-title":"J. Pathol."},{"issue":"6","key":"10.1016\/j.critrevonc.2017.03.020_bib0505","first-page":"387","article-title":"Cancer and infection: estimates of the attributable fraction in 1990","volume":"6","author":"Pisani","year":"1997","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"Suppl. (2)","key":"10.1016\/j.critrevonc.2017.03.020_bib0510","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.2307\/3578893","article-title":"Kuramoto A, et al. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950\u20131987","volume":"137","author":"Preston","year":"1994","journal-title":"Radiat. Res."},{"issue":"39","key":"10.1016\/j.critrevonc.2017.03.020_bib0515","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.1038\/sj.onc.1208968","article-title":"Global epidemiology of HTLV-I infection and associated diseases","volume":"24","author":"Proietti","year":"2005","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.critrevonc.2017.03.020_bib0520","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1097\/00000478-199211000-00006","article-title":"Prethymic adult lymphoblastic lymphoma: a clinicopathologic and immunohistochemical analysis","volume":"16","author":"Quintanilla-Martinez","year":"1992","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.critrevonc.2017.03.020_bib0525","unstructured":"RARECAREnet, Avaialble at: http:\/\/www.rarecarenet.eu\/rarecarenet\/."},{"issue":"2","key":"10.1016\/j.critrevonc.2017.03.020_bib0530","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/pbc.20550","article-title":"Gene expression profiling reveals intrinsic differences between T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma","volume":"47","author":"Raetz","year":"2006","journal-title":"Pediatr. Blood Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2017.03.020_bib0535","first-page":"416","article-title":"Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report","volume":"95","author":"Reiter","year":"2000","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.critrevonc.2017.03.020_bib0540","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0161-5890(97)00031-X","article-title":"Immunoglobulin VH gene replacements in aT-cell lymphoblastic lymphoma","volume":"34","author":"Rosenquist","year":"1997","journal-title":"Mol. Immunol."},{"issue":"2","key":"10.1016\/j.critrevonc.2017.03.020_bib0545","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1309\/AJCPZ7E9IMXVSNPT","article-title":"Acute lymphoblastic leukemia with Burkitt-like morphologic features and high myeloperoxidase activity","volume":"132","author":"Rytting","year":"2009","journal-title":"Am. J. Clin. Pathol."},{"issue":"10","key":"10.1016\/j.critrevonc.2017.03.020_bib0550","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/0277-5379(88)90053-3","article-title":"Lymphoblastic lymphoma in adults: a clinicopathological study of 34 cases treated at the Institut Gustave-Roussy","volume":"24","author":"Salloum","year":"1988","journal-title":"Eur. J. Cancer Clin. Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2017.03.020_bib0555","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/leu.2008.400","article-title":"Effective treatment of advanced-stage childhood lymphoblastic lymphoma without prophylactic cranial irradiation: results of St Jude NHL13 study","volume":"23","author":"Sandlund","year":"2009","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.critrevonc.2017.03.020_bib0560","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S1470-2045(14)70282-7","article-title":"Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study","volume":"15","author":"Sant","year":"2014","journal-title":"Lancet Oncol."},{"issue":"Suppl. (1)","key":"10.1016\/j.critrevonc.2017.03.020_bib0565","first-page":"42","article-title":"Autologous bone marrow transplantation for adult advanced stage lymphoblastic lymphoma in first CR. A study of the NHLCSG","volume":"5","author":"Santini","year":"1991","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.critrevonc.2017.03.020_bib0570","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1365-2141.2011.08788.x","article-title":"Chromosome abnormalities in advanced stage T-cell lymphoblastic lymphoma of children and adolescents: a report from Japanese Paediatric Leukaemia\/Lymphoma Study Group (JPLSG) and review of the literature","volume":"154","author":"Sekimizu","year":"2011","journal-title":"Br. J. Haematol."},{"issue":"9","key":"10.1016\/j.critrevonc.2017.03.020_bib0575","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1001\/archderm.144.9.1155","article-title":"Cutaneous precursor B-cell lymphoblastic lymphoma in 2 adult patients: clinicopathologic and molecular cytogenetic studies with a review of the literature","volume":"144","author":"Shafer","year":"2008","journal-title":"Arch. Dermatol."},{"issue":"6","key":"10.1016\/j.critrevonc.2017.03.020_bib0580","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ng.585","article-title":"Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk","volume":"42","author":"Sherborne","year":"2010","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.critrevonc.2017.03.020_bib0585","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1200\/JCO.1986.4.1.57","article-title":"Lymphoblastic lymphoma in adults","volume":"4","author":"Slater","year":"1986","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2017.03.020_bib0590","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/(SICI)1097-0215(19991210)83:6<718::AID-IJC3>3.0.CO;2-T","article-title":"Parental occupation and other factors and cancer risk in children: II. Occupational factors","volume":"83","author":"Smulevich","year":"1999","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2017.03.020_bib0595","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/annonc\/mdl426","article-title":"Primary therapy for adults with T-cell lymphoblastic lymphoma with hematopoietic stem-cell transplantation results in favorable outcomes","volume":"18","author":"Song","year":"2007","journal-title":"Ann. Oncol."},{"issue":"10","key":"10.1016\/j.critrevonc.2017.03.020_bib0600","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/S0046-8177(97)90254-9","article-title":"MIC2: TdT, bcl-2, and CD34 expression in paraffin-embedded high-grade lymphoma\/acute lymphoblastic leukemia distinguishes between distinct clinicopathologic entities","volume":"28","author":"Soslow","year":"1997","journal-title":"Hum. Pathol."},{"issue":"1","key":"10.1016\/j.critrevonc.2017.03.020_bib0605","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/pbc.21823","article-title":"Bone marrow minimal disseminated disease (MDD) and minimal residual disease (MRD) in childhood T-cell lymphoblastic lymphoma stage III, detected by flowcytometry (FC) and real-time quantitative polymerase chain reaction (RQ-PCR)","volume":"52","author":"Stark","year":"2009","journal-title":"Pediatr. Blood Cancer"},{"issue":"10","key":"10.1016\/j.critrevonc.2017.03.020_bib0610","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1002\/1097-0142(19810515)47:10<2510::AID-CNCR2820471034>3.0.CO;2-8","article-title":"Lymphoblastic lymphoma in adults","volume":"47","author":"Streuli","year":"1981","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.critrevonc.2017.03.020_bib0615","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/oxfordjournals.annonc.a058107","article-title":"Adult lymphoblastic lymphoma: high incidence of central nervous system relapse in patients treated with the Stanford University protocol","volume":"3","author":"Sweetenham","year":"1992","journal-title":"Ann. Oncol."},{"issue":"7","key":"10.1016\/j.critrevonc.2017.03.020_bib0620","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1200\/JCO.1994.12.7.1358","article-title":"High-dose therapy and autologous bone marrow transplantation for adult patients with lymphoblastic lymphoma: results of the European Group for Bone Marrow Transplantation","volume":"12","author":"Sweetenham","year":"1994","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.critrevonc.2017.03.020_bib0625","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1200\/JCO.2001.19.11.2927","volume":"19","author":"Sweetenham","year":"2001","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.critrevonc.2017.03.020_bib0630","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1182\/blood.V93.12.4079","article-title":"Ig heavy chain gene rearrangements in T-cell acute lymphoblastic leukemia exhibit predominant DH6-19 and DH7-27 gene usage: can result in complete V-D-J rearrangements, and are rare in T-cell receptor alpha beta lineage","volume":"93","author":"Szczepanski","year":"1999","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.critrevonc.2017.03.020_bib0635","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1002\/pbc.24149","article-title":"Outcome of newly diagnosed children and adolescents with localized lymphoblastic lymphoma treated on Children\u2019s Oncology Group trial A5971: a report from the Children\u2019s Oncology Group","volume":"59","author":"Termuhlen","year":"2012","journal-title":"Pediatr. Blood Cancer"},{"issue":"6","key":"10.1016\/j.critrevonc.2017.03.020_bib0640","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/bjh.12460","article-title":"Disseminated lymphoblastic lymphoma in children and adolescents: results of the COG A5971 trial: a report from the Children\u2019s Oncology Group","volume":"162","author":"Termuhlen","year":"2013","journal-title":"Br. J. Haematol."},{"issue":"6","key":"10.1016\/j.critrevonc.2017.03.020_bib0645","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1182\/blood-2003-12-4428","article-title":"Outcome with the hyper-CVAD regimens in lymphoblastic lymphoma","volume":"104","author":"Thomas","year":"2004","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.critrevonc.2017.03.020_bib0650","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/ng.432","article-title":"Germline genomic variants associated with childhood acute lymphoblastic leukemia","volume":"41","author":"Trevino","year":"2009","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.critrevonc.2017.03.020_bib0655","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/cncr.22807","volume":"110","author":"Tsukamoto","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2017.03.020_bib0660","series-title":"The Joint United Nations Programme on HIV\/AIDS. Global Report, UNAIDS Report on the Global AIDS Epidemic","author":"UNAIDS","year":"2013"},{"issue":"9","key":"10.1016\/j.critrevonc.2017.03.020_bib0665","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1080\/10428190701509772","article-title":"Is there a difference in childhood T-cell acute lymphoblastic leukaemia and T-cell lymphoblastic lymphoma?","volume":"48","author":"Uyttebroeck","year":"2007","journal-title":"Leuk. Lymphoma"},{"issue":"6","key":"10.1016\/j.critrevonc.2017.03.020_bib0670","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.ejca.2008.02.011","article-title":"Treatment of childhood T-cell lymphoblastic lymphoma according to the strategy for acute lymphoblastic leukaemia, without radiotherapy: long term results of the EORTC CLG 58881 trial","volume":"44","author":"Uyttebroeck","year":"2008","journal-title":"Eur. J. Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2017.03.020_bib0675","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0002-9343(97)89488-0","article-title":"Allogeneic bone marrow transplantation for poor-prognosis lymphoma: response, toxicity and survival depend on disease histology","volume":"100","author":"van Besien","year":"1996","journal-title":"Am. J. Med."},{"issue":"4","key":"10.1016\/j.critrevonc.2017.03.020_bib0680","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1200\/JCO.1992.10.4.644","article-title":"Autologous bone marrow transplantation for adult poor-risk lymphoblastic lymphoma in first remission","volume":"10","author":"Verdonck","year":"1992","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2017.03.020_bib0685","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1289\/ehp.1002318","article-title":"Occupational benzene exposure and the risk of lymphoma subtypes: a meta-analysis of cohort studies incorporating three study quality dimensions","volume":"119","author":"Vlaanderen","year":"2011","journal-title":"Environ. Health Perspect."},{"issue":"1","key":"10.1016\/j.critrevonc.2017.03.020_bib0690","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF02935915","article-title":"A meta-analysis of epidemiological studies on the relationship between occupational electromagnetic field exposure and the risk of adult leukemia","volume":"5","author":"Wang","year":"2000","journal-title":"Environ. Health Prev. Med."},{"issue":"9","key":"10.1016\/j.critrevonc.2017.03.020_bib0695","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1200\/JCO.1983.1.9.537","article-title":"Long-term results of the APO protocol (vincristine: doxorubicin [adriamycin], and prednisone) for treatment of mediastinal lymphoblastic lymphoma","volume":"1","author":"Weinstein","year":"1983","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.critrevonc.2017.03.020_bib0700","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1002\/pbc.25470","article-title":"Safe integration of nelarabine into intensive chemotherapy in newly diagnosed T-cell acute lymphoblastic leukemia: children\u2019s Oncology Group Study AALL0434","volume":"62","author":"Winter","year":"2015","journal-title":"Pediatr. Blood Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2017.03.020_bib0705","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/1097-0142(197601)37:1<123::AID-CNCR2820370119>3.0.CO;2-7","article-title":"Non-Hodgkin\u2019s lymphoma in children: a comparative study of two modalities of therapy","volume":"37","author":"Wollner","year":"1976","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.critrevonc.2017.03.020_bib0710","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s00277-006-0169-2","article-title":"Autologous peripheral blood stem cell transplantation in children with non-Hodgkin\u2019s lymphoma: a report from the Korean society of pediatric hematology-oncology","volume":"85","author":"Won","year":"2006","journal-title":"Ann. Hematol."},{"issue":"3","key":"10.1016\/j.critrevonc.2017.03.020_bib0715","doi-asserted-by":"crossref","first-page":"624","DOI":"10.3109\/10428194.2013.820293","article-title":"CD30 expression in acute lymphoblastic leukemia as assessed by flow cytometry analysis","volume":"55","author":"Zheng","year":"2014","journal-title":"Leuk. Lymphoma"},{"issue":"5\u20136","key":"10.1016\/j.critrevonc.2017.03.020_bib0720","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3109\/10428199609054867","article-title":"Adult lymphoblastic lymphoma: clinical features and prognostic factors in 53 patients","volume":"23","author":"Zinzani","year":"1996","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.critrevonc.2017.03.020_bib0725","first-page":"124","article-title":"The safety and activity of BMS-906024, a gamma secretase inhibitor (GSI) with anti-Notch activity, in patients with relapsed T-cell Acute Lymphoblastic Leukemia (T-ALL): initial results of a phase 1 trial","author":"Zweidler-McKay","year":"2014","journal-title":"Blood"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842816302438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842816302438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T21:50:38Z","timestamp":1657230638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842816302438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":145,"alternative-id":["S1040842816302438"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2017.03.020","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lymphoblastic lymphoma","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2017.03.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}